Navigation

tetanus immune globulin (TIG) (Hyper Tet, HyperTET S/D, TIG)

 

Classes: Immune Globulins

Dosing and uses of Hyper Tet, HyperTET S/D (tetanus immune globulin (TIG))

 

Adult dosage forms and strengths

powder for injection

  • 250 units

 

Tetanus

Prophylaxis: 250 Units IM (single dose)

Active tetanus: 3000-6000 Units

Clean minor wound

  • # doses unknown or 0-2 doses; toxoid only
  • >3 doses; toxoid if >10 years ago

All other wounds

  • # doses unknown or 0-1 doses; toxoid plus IG
  • 2 doses; toxoid, but no IG if wound <24 hours old
  • >3 doses; toxoid if >5 years ago, and no IG

 

Other Indications & Uses

Postexposure prophylaxis

 

Pediatric dosage forms and strengths

powder for injection

  • 250 units

 

Tetanus

>7 years old: 250 Units IM (single dose)

<7 years old: 4 Unit/kg or 250 Units Im

 

Hyper Tet, HyperTET S/D (tetanus immune globulin (TIG)) adverse (side) effects

Frequency not defined

Urticaria

Injection site pain

N/V

Fever

Lethargy

Chest tightness

Anaphylaxis

Angioneurotic edema

Nephrotic syndrome (rare)

 

Warnings

Contraindications

Hypersensitivity to gamma globulin, IgA, thimerosaL

 

Cautions

Thrombocytopenia or coagulation disorders that contraindicate IM inj

Made from human plasma, small risk of viral transmission through admin

 

Pregnancy and lactation

Pregnancy category: C

Lactation: not known if excreted in breast milk, no adverse effects reported

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Hyper Tet, HyperTET S/D (tetanus immune globulin (TIG))

Half-Life: 28 d

 

Mechanism of action

Human immune globulins from donors